D
TScan Therapeutics, Inc. TCRX
$1.82 $0.084.60% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -16.71% -13.22% -82.58% -29.96% -31.67%
Total Depreciation and Amortization -37.46% -45.93% -44.45% -20.14% -13.89%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 21.71% 29.88% 217.25% -8.13% 48.61%
Change in Net Operating Assets -82.32% -202.70% 184.85% -100.98% 407.03%
Cash from Operations -26.85% -28.42% -15.34% -448.24% -19.09%
Capital Expenditure -48.38% -117.30% -89.34% 3.45% -105.24%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 251.32% -59.15% 1,083.08% -34.98% --
Cash from Investing 243.66% -62.59% 1,326.71% -34.09% -7,927.62%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -99.43% -- 1,889.47% -- -23.03%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -100.06% -- -- 100.00% 38.83%
Cash from Financing -99.93% -303.49% 240,373.68% 588.10% 19.10%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash -84.96% -443.60% 308.72% -103.25% -10.23%